Nature Reviews Drug Discovery

Show Articles
Journal Properties
  • Country
    United Kingdom
  • Language
    English
  • Number of Articles
    6,026
  • Abbreviation
    Nat Rev Drug Discovery
  • ISSN
    1474-1776
  • e-ISSN
    1474-1784
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • DOAJ (latest)
Journal Properties
  • Medicine
    Public aspects of medicine
    Toxicology
    Poisons
    Medicine
    Therapeutics
    Pharmacology
    Technology
    Chemical technology
    Biotechnology
  • website
Description
Nature Reviews Drug Discovery is a leading review journal that provides comprehensive and authoritative coverage of the latest advances in drug discovery and development. It serves as an invaluable resource for researchers, clinicians, and industry professionals seeking to stay informed about this dynamic and multidisciplinary field. The journal's scope encompasses a wide range of topics, from target identification and validation to preclinical and clinical development, regulatory affairs, and commercialization. Nature Reviews Drug Discovery publishes high-quality reviews, perspectives, and highlights that synthesize complex information and provide expert insights. Indexed in prominent databases like PubMed, Scopus, and Web of Science, it ensures broad visibility and accessibility. The primary audience consists of researchers, drug developers, and academics involved in the pharmaceutical industry. Through its rigorous peer-review process and commitment to excellence, Nature Reviews Drug Discovery plays a vital role in advancing the efficiency and effectiveness of drug development. It welcomes submissions that offer critical analyses and forward-looking perspectives, ultimately contributing to the discovery of novel and improved therapies for human diseases.